Polycystic ovary syndrome in adolescent girls

Seminars in Pediatric Surgery

Volumn 14, Issue 2, 2005, Pages 111-117

  Pfeifer, Samantha M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Hirsutism; Insulin resistance; Metformin; Obesity; Oligomenorrhea; Polycystic ovary syndrome

Indexed keywords

ANDROGEN; ANTIANDROGEN; INSULIN SENSITIZING AGENT; ORAL CONTRACEPTIVE AGENT;

ACNE; ADOLESCENT; ANDROGEN SYNTHESIS; ANOVULATION; ARTICLE; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SCREENING; FEMALE; GLUCOSE TOLERANCE; HIRSUTISM; HUMAN; INSULIN RESISTANCE; OBESITY; OLIGOMENORRHEA; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; SYMPTOM; WEIGHT GAIN; WEIGHT REDUCTION;

EID: 17444394871     PISSN: 10558586     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.sempedsurg.2005.01.007     Document Type: Article

References (51)

1. A. Dunaif Insulin resistance and the polycystic ovary syndrome mechanism and implications for pathogenesis Endocr Rev 18 1997 774 800
2. R. Azziz, K.S. Woods, R. Reyna The prevalence and features of the polycystic ovary syndrome in an unselected population J Clin Endocrinol Metab 89 2004 2745 2749
3. J. Waldstreicher, N.F. Santoro, J.E. Hall Hyperfunction of the hypothalamic-pituitary axis in women with polycystic ovarian disease indirect evidence for partial gonadotroph desensitization J Clin Endocrinol Metab 66 1988 165 172
4. D. Apter, T. Butzow, G.A. Laughlin Accelerated 24 h luteinizing hormone pulsatile activity in adolescent girls with ovarian hyperandrogenism relevance to the developmental phase of polycystic ovarian disease J Clin Endocrinol Metab 79 1994 99 125
5. D. Apter, T. Butzow, G.A. Laughlin Metabolic features of polycystic ovary syndrome are found in adolescent girls with hyperandrogenism J Pediatr Endocrinol Metab 80 1995 2966 2973
6. R. Azziz We should avoid the indiscriminate use of insulin sensitizers in women with polycystic ovary syndrome Fertil Steril 80 2003 264 265
7. A. Dunaif Hyperandrogenemia is necessary but not sufficient for polycystic ovary syndrome Fertil Steril 80 2003 262 263
8. A. Dunaif, K.R. Segal, W. Futterweit Profound peripheral insulin resistance, independent of obesity, in the polycystic ovary syndrome Diabetes 38 1989 1165 1174
9. A. Dunaif, J. Xia, C.B. Book Excessive insulin receptor phosphorylation in cultured fibroblast and skeletal muscle J Clin Invest 96 1995 801 810
10. L. Zhang, H. Rodriguez, S. Ohno Serine phosphorylation of human P450c17 increases 17,20-lyase activity implications for adrenarche and the polycystic ovary syndrome Proc Natl Acad Sci 92 1995 10619 10623
11. The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group Revised 2003 consensus on diagnostic criteria and long term health risks related to polycystic ovary syndrome Fertil Steril 81 2004 19 25
12. M.H.A. van Hooff, F.J. Voorhorst, M.B.H. Kaptein Relationship of the menstrual cycle pattern in 14-17 year old adolescents with gynaecological age, body mass index and historical parameters Hum Reprod 13 1998 2252 2260
13. L. Ibanez, N. Potau, M. Zampolli Hyperinsulinemia in postpubertal girls with a history of premature pubarche and functional ovarian hyperandrogenism J Clin Endocrinol Metab 81 1996 1237 1243
14. P. Timpatanapong, A. Rojanasakul Hormonal profiles and prevalence of polycystic ovary syndrome in women with acne J Dermatol 24 1997 223 229
15. S.M. Slayden, C. Moran, W.M. Sams Jr Hyperandrogenemia in patients presenting with acne Fertil Steril 75 2001 889 892
16. M.H.A. van Hooff, F.J. Voorhorst, M.B.H. Kaptein Polycystic ovaries in adolescents and the relationship with menstrual cycle patterns, luteinizing hormone, androgens, and insulin Fertil Steril 74 2000 49 58
17. A. Gadir, M.S. Khatim, R.S. Mowafi Implications of ultrasonically diagnosed polycystic ovaries I. Correlations with basal hormonal profiles Hum Reprod 7 1992 453 457
18. E. Oppenheimer, B. Linder, J. Dimartino-Nardi Decreased insulin sensitivity in prepubertal girls with premature adrenarche and acanthosis nigricans J Clin Endocrinol Metab 80 1995 614 618
19. V. Dramusic, V.H.H. Goh, U. Rajan Clinical, endocrinologic, and ultrasound features of polycystic ovary syndrome in Singaporean adolescents J Pediatr Adolesc Gynecol 10 1997 125
20. R. Azziz The time has come to simplify the evaluation of the hirsute patient Fertil Steril 74 2000 870 872
21. M.E. Silfen, M.R. Denburg, A.M. Manibo Early endocrine, metabolic, and sonographic characteristics of polycystic ovary syndrome (PCOS) comparison between non-obese and obese adolescents J Clin Endocrinol Metab 88 2003 4682 4688
22. R.S. Legro, D. Finegood, A. Dunaif A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome J Clin Endocrinol Metab 83 1998 2694 2698
23. R.S. Legro Detection of insulin resistance and its treatment in adolescents with polycystic ovary syndrome J Pediatr Endocrinol Metab 15 2002 1367 1378
24. R.S. Legro, A.R. Kunselman, W.C. Dodson Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome a prospective, controlled study in 254 affected women J Clin Endocrinol Metab 84 1999 165 169
25. M.R. Palmert, C.M. Gordon, A.I. Kartashov Screening for abnormal glucose tolerance in adolescents with polycystic ovary syndrome J Clin Endocrinol Metab 87 2002 1017 1023
26. W.C. Knowler, E. Barrett-Connor, S.E. Fowler Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin N Engl J Med 346 2002 393 403
27. E. Dahlgreen, P.O. Janson, S. Johansson Polycystic ovary syndrome and risk for myocardial infarction evaluated from a risk factor model based on a prospective study of women Acta Obstet Gynecol Scand 71 1992 599 604
28. D.A. Ehrmann, R.B. Barnes, R.L. Rosenfeld Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome Diabetes Care 22 1999 141 146
29. S. Wild, T. Pierpoint, P. McKeigue Cardiovascular disease in women with polycystic ovary syndrome at long term follow-up a retrospective cohort study Clin Endocrinol 52 2000 595 600
30. E. Talbott, D. Guzick, A. Clerici Coronary risk factors in women with polycystic ovary syndrome Arterioscler Thromb Vasc Biol 15 1995 821 826
31. T. Pierpoint, M. McKeigue, A.J. Isaacs Mortality of women with polycystic ovary syndrome at long term follow-up J Clin Epidemiol 51 1998 581 586
32. D.S. Kiddy, D. Hamilton-Fairley, A. Bush Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome Clin Endocrinol (Oxf) 36 1992 105 111
33. A.M. Clark, B. Thornley, L. Tomlinson Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment Hum Reprod 13 1998 1502 1505
34. M.M. Huber-Buchholz, D.G.P. Carey, R.J. Norman Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome role of insulin sensitivity and luteinizing hormone J Clin Endocrinol Metab 84 1999 1470 1474
35. D.M. Bravata, L. Sanders, J. Huang Efficacy and safety of low-carbohydrate diets a systematic review JAMA 289 2003 1837 1850
36. G.D. Foster, H.R. Wyatt, J.O. Hill A randomized trial of a low-carbohydrate diet for obesity N Engl J Med 348 2003 2082 2090
37. L.J. Moran, M. Noakes, P.M. Clifton Dietary composition in restoring reproductive and metabolic physiology in overweight women with polycystic ovary syndrome J Clin Endocrinol Metab 88 2003 812 819
38. M.T. Korytkowski, M. Mokan, M.J. Horwitz Metabolic effects of oral contraceptives in women with polycystic ovary syndrome J Clin Endocrinol Metab 80 1995 3327 3334
39. C. Jung-Hoffmann, H. Kuhl Divergent effects of two low-dose oral contraceptives on sex hormone-binding globulin and free testosterone Am J Obstet Gynecol 156 1987 199 203
40. R.T. Burkman The role of oral contraceptives in the treatment of hyperandrogenic disorders Am J Med 98 1995 130S 136S
41. P. Moghetti, F. Tosi, A. Tosti Comparison of spironolactone, flutamide, and finasteride efficacy in the treatment of hirsutism a randomized double blind, placebo-controlled trial J Clin Endocrinol Metab 85 2000 89 94
42. M. Tartagni, L.M. Schonauer, M.A. De Salvia Comparison of Diane 35 and Diane 35 plus finasteride in the treatment of hirsutism Fertil Steril 73 2000 718 723
43. R. Fleming, Z.E. Hopkinson, A.M. Wallace Ovarian function and metabolic factors in women with oligomenorrhea treated with metformin in a randomized double blind placebo controlled trial J Clin Endocrinol Metab 87 2002 569 574
44. C.J. Glueck, P. Wang, R. Fontaine Metformin to restore normal menses in oligo-amenorrheic teenage girls with polycystic ovary syndrome (PCOS) J Adol Health 29 2001 160 169
45. P. Moghetti, R. Castello, C. Negri Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation J Clin Endocrinol Metab 85 2000 139 146
46. J.M. Lord, I.H. Flight, R.J. Norman Metformin in polycystic ovary syndrome a systematic review and meta-analysis Br Med J 327 2003 951 953
47. M.A. Ganie, M.L. Khurana, M. Gulati Comparison of efficacy of spironolactone with metformin in the management of polycystic ovary syndrome an open-labeled study J Clin Endocrinol Metab 89 2004 2756 2762
48. L.C. Morin-Papunen, I. Vauhkonen, R.M. Koivunen Endocrine and metabolic effects of metformin versus ethinyl estradiol-cyproterone acetate in obese women with polycystic ovary syndrome a randomized study J Clin Endocrinol Metab 85 2000 3161
49. L.C. Morin-Papunen, R.M. Koivunen, A. Roukonen Metformin therapy improves the menstrual pattern with minimal endocrine and metabolic effects in women with polycystic ovary syndrome Fertil Steril 69 1998 691 696
50. R. Pasquali, A. Gambineri, D. Biscotti Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome J Clin Endocrinol Metab 85 2000 2767 2774
51. L. Ibanez, K. Ong, A. Ferrer Low-dose flutamaide-metfomrin therapy reverses insulin resistance and reduces fat mass in non-obese adolescents with ovarian hyperandrogenism J Clin Endocrinol Metab 88 2003 2600 2606